ClinicalTrials.gg
CompletedNCT03437980Updated Sep 18, 2020

Propofol Spinal Procedural Sedation for Cesarean Section

An interventional study of propofol in Patient Compliance, sponsored by Mansoura University. Completed at 3 sites in Egypt. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2020-09-18.

Sponsored by Mansoura University · Not applicable, Interventional, and Supportive care

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
228
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 10 studies in Patient Compliance with a site in Egypt — 2 open to participants now, 2 under way, none of them phase 3. Patient Compliance · Egypt.

Started
2018
with 1 other
No phase
5 of 10
2 open now
Registered
3rd of 10
by date
Lead sponsor
2 of 10
Mansoura University

Among the 10 studies in Patient Compliance with a site in Egypt, this one is one of 2 that started in 2018, is one of 5 with no phase, and was the 3rd registered.

Patient Compliance

752 studies on the registry are indexed under Patient Compliance; 72 are open to participants now.

Browse Patient Compliance studies →

Open to participants now

2 of the 10 studies in Patient Compliance with a site in Egypt are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 45 Patient Compliance studies recruiting now, 25 (56%) set no upper age limit and 13 (29%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.

This study: 18 Years to 40 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Patient Compliance with a site in Egypt, or all of them as a file.
02

Study summary

Patient's safety and satisfaction are major concerns of anesthesiologists and obstetricians. According to evidence, guidelines and quality markers, regional anesthesia is preferred over general anesthesia in obstetric surgery. A high level of anxiety is present in obstetric patients preoperatively. Patients with high anxiety tend to prefer general anesthesia for cesarean section. The anxiety can be reduced variably by non-pharmacologic and pharmacologic methods. The evidence supports the benefits of procedural sedation for distressed, anxious pregnant women.

Read the detailed description

Propofol provides short onset, rapid predictable action, anxiolysis and amnesia and it is more effective than benzodiazepines. Using propofol infusion in low doses during spinal injection in CS did not adversely affect the Apgar scores or the neurological and adaptive fetal outcomes. The general consensus is that procedural sedation is not a routine for spinal interventions, but required for anxious patients. Our hypothesis is that, with the high prevalence of maternal anxiety during cesarean section, ensuring painless comfortable spinal anesthesia may increase the acceptance rate of regional anesthesia during cesarean section.

03

Conditions studied

  • Patient Compliance

Browse trials for

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients scheduled for elective cesarean section,
  • Age: 18 - 40 years,
  • I - III,
  • Patients may present any of the following conditions:
  • Respiratory diseases as bronchial asthma
  • Hepatic compromise,
  • Preeclampsia,
  • Anemia with 10 g/dl,
  • Previous sections,
  • Obese with more than 35%,
  • Any criteria of difficult intubation, Compromised fetus as premature delivery, History of complications or non-satisfaction after general anesthesia during previous cesarean section,

Exclusion criteria

Exclusion Criteria:

  • Patients refusing to participate in the study,
  • Known psychiatric disease,
  • Addiction medications,
  • Communication barrier,
  • Absolute or relative for spinal anesthesia,
  • Bad obstetric history, complicated pregnancy, congenital fetal anomaly.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
228 participants (actual)

Study arms

  • Experimental
    propofol spinal acceptance

    The surgeon and the anesthetist will discuss the exclusion criteria. Then they will discuss the information's about spinal and general anesthesia with the illegible patients, also reply the patient's questions in a preoperative visit. The primary decision for the patient; either spinal or general anesthesia will be recorded. The patients refusing spinal anesthesia will be discussed again to detect the rate of acceptance of spinal anesthesia if propofol sedation is ensured during the procedure to provide a painless spinal injection. The final decision will be applied; either spinal with procedural sedation, or general anesthesia.

    Drug: propofol

Interventions

  • A bolus of 0.7 mg/kg will be given initially, additional incremental doses of 20 mg propofol will be given if the patient complained of pain or moved arms towards the back. Patients will be sitting on the middle of the operating table facing towards the table's foot. The table's foot will be dropped 45 degrees for a comfortable chair position, Monitoring through pulse oximeter (SaO2), non-invasive blood pressure (NIBP) adjusted every 2 minutes automatic measuring and capnography tube in contact with nostrils.

    Also known as: propofol procedural sedation

06

What researchers measure

Primary outcomes

  1. The rate of acceptance of spinal anesthesia if propofol sedation is added during the procedure.

    percent

    Time frame: 30 minutes preoperative.

Secondary outcomes

  1. The rate of initial acceptance of spinal anesthesia without sedation.

    percent

    Time frame: 30 minutes preoperative.

  2. The anxiety score.

    by the visual analogue score from 0-10, where 10 is the maximum anxiety level.

    Time frame: 30 minutes preoperative,10 minutes after spinal injection, and 30 minutes after stay at recovery room.

Other outcomes

  1. The patient satisfaction regards the spinal anesthesia decision.

    The patients express thier satisfaction with the spinal decision on a visual analogue score, ranging from 0 to 10, where 0 is the minimum and 10 is the maximum satisfaction level.

    Time frame: 30 minutes at recovery room.

  2. The total utilized dose of propofol.

    milligram

    Time frame: 1 minute after completion of spinal procedure, and 5 minutes at the end of cesarean section.

  3. The rate of premature termination of spinal procedure (failure rate).

    percent

    Time frame: 20 minutes preoperative.

  4. The sedation score.

    using modified Ramsay scale, 1. Anxious, 2. Cooperative, oriented, tranquil. 3. Responsive to commands only. If Asleep. 4. Brisk response to light glabellar tap or loud auditory stimulus. 5. Sluggish response to light glabellar tap or loud auditory stimulus.

    Time frame: determined 1 minutes after following spinal injection. then again after 10 minutes.

  5. The infant Apgar score.

    A measure of the physical condition of a newborn infant. Adding points (2, 1, or 0) for heart rate, respiratory effort, muscle tone, response to stimulation, and skin coloration; ranges from 0- 10, score of ten represents the best possible condition.

    Time frame: 0 and 5 minutes after delivery.

  6. Patient's choice of anesthesia next time.

    spinal or general anesthesia.

    Time frame: 30 minutes after shifting the patient to recovery room.

  7. The incidence of desaturation during propofol spinal procedural sedation.

    in percent, desaturation defined as oxygen saturation less than 90%

    Time frame: 20 minutes preoperative.

  8. The incidence of hypotension during propofol spinal procedural sedation.

    in percent, hypotension defined as mean blood pressure less than 60 millimeter mercury.

    Time frame: 20 minutes preoperative.

07

Study locations

3 sites
  • Delta Hospital
    Mansourah, Dakahlya 35516, Egypt
  • Mansoura University Hospital
    Mansourah, Dakahlya 35516, Egypt
  • Zagazig University Hospital
    Zagazig, Sharkya 44519, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2018 to primary completion in Jul 2018, 3 months.

Of 224 non-industry interventional studies with no phase under Patient Compliance, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 38. This study's 3 months is below that.

Counting every sponsor, half of 237 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2018
First posted
Feb 19, 2018
StartActual
Apr 1, 2018
Primary completionActual
Jul 10, 2018
CompletionActual
Sep 10, 2018
Last update
Sep 18, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03437980
Responsible party
Alaa Mazy Mazy (associate professor of anesthesia and surgical intensive care, Mansoura University) — Principal investigator
First posted
Feb 19, 2018
Start date
Apr 1, 2018
Primary completion
Jul 10, 2018
Completion
Sep 10, 2018
Last update
Sep 18, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Propofol

Start the discussion